Valuation RaySearch Laboratories AB London S.E.
Stocks
0GRZ
SE0000135485
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 182.25 SEK | +2.30% |
|
+0.39% | -20.24% |
| 08-07 | RaySearch wins order for additional RayStation licenses from UNC | FW |
| 08-04 | DNB Carnegie cuts RaySearch price target to 250 kronor (290), reiterates buy | FW |
Company Valuation: RaySearch Laboratories AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,937 | 2,331 | 3,096 | 7,405 | 7,816 | 6,167 | - | - |
| Change | - | 20.35% | 32.79% | 139.2% | 5.56% | -21.1% | - | - |
| Enterprise Value (EV) 1 | 2,397 | 2,727 | 3,281 | 7,414 | 7,804 | 6,336 | 6,192 | 5,973 |
| Change | - | 13.78% | 20.33% | 125.95% | 5.26% | -18.8% | -2.27% | -3.54% |
| P/E | -40.9x | 98.6x | 37.9x | 36.4x | 34.3x | 23.1x | 18.9x | 15.3x |
| PBR | 2.98x | 3.55x | 4.21x | 8.45x | 7.93x | 6.95x | 5.71x | 4.68x |
| PEG | - | -1x | 0x | 0x | 2.9x | 1.3x | 0.9x | 0.7x |
| Capitalization / Revenue | 3.02x | 2.76x | 3.03x | 6.21x | 5.81x | 4.42x | 3.78x | 3.34x |
| EV / Revenue | 3.74x | 3.23x | 3.21x | 6.22x | 5.81x | 4.54x | 3.8x | 3.24x |
| EV / EBITDA | 12.2x | 8.03x | 8.2x | 13.3x | 13.4x | 9.85x | 8.33x | 6.91x |
| EV / EBIT | -44.8x | 63.9x | 28.6x | 28.5x | 26.7x | 18.2x | 14.2x | 11x |
| EV / FCF | 234x | - | - | - | 21.7x | 35.6x | 21.9x | 15.8x |
| FCF Yield | 0.43% | - | - | - | 4.6% | 2.81% | 4.57% | 6.34% |
| Dividend per Share 2 | - | - | 0.7 | 3 | 3 | 4 | 4.76 | 5.87 |
| Rate of return | - | - | 0.78% | 1.39% | 1.32% | 2.22% | 2.65% | 3.26% |
| EPS 2 | -1.38 | 0.69 | 2.38 | 5.94 | 6.65 | 7.8 | 9.52 | 11.74 |
| Distribution rate | - | - | 29.4% | 50.5% | 45.1% | 51.3% | 50% | 50% |
| Net sales 1 | 641.1 | 843.6 | 1,022 | 1,192 | 1,344 | 1,396 | 1,630 | 1,846 |
| EBITDA 1 | 196.7 | 339.7 | 400.1 | 558 | 583.5 | 643 | 743.5 | 864 |
| EBIT 1 | -53.5 | 42.7 | 114.9 | 260.5 | 292.3 | 348.5 | 435 | 544.5 |
| Net income 1 | -47.3 | 23.8 | 81.57 | 203.5 | 227.8 | 265 | 320 | 394 |
| Net Debt 1 | 459.7 | 395.9 | 185.7 | 9.2 | -12.5 | 169 | 25 | -194 |
| Reference price 2 | 56.50 | 68.00 | 90.30 | 216.00 | 228.00 | 179.90 | 179.90 | 179.90 |
| Nbr of stocks (in thousands) | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | 34,283 | - | - |
| Announcement Date | 2/23/22 | 2/28/23 | 2/23/24 | 2/21/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 36.03x | 8.3x | 18.37x | -.--% | 37.44B | |
| 80.68x | 69.58x | 86.68x | 0.43% | 12.99B | |
| 78.57x | 11.57x | 50.23x | 0.74% | 5.44B | |
| -34.52x | 10.23x | -55.4x | - | 2.49B | |
| -6.15x | 54.13x | -5.34x | - | 1.84B | |
| 37.43x | - | - | -.--% | 1.68B | |
| -108.55x | - | - | - | 1.02B | |
| 6.27x | - | - | - | 915M | |
| 121x | - | - | 1.1% | 833M | |
| Average | 23.42x | 30.76x | 18.91x | 0.46% | 7.18B | |
| Weighted average by Cap. | 43.09x | 23.30x | 32.22x | 0.18% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RAY B Stock
- 0GRZ Stock
- Valuation RaySearch Laboratories AB
Select your edition
All financial news and data tailored to specific country editions
